Why ARTV? Artiva Biotherapeutics, Inc. Analysis, Price & AI Insights | Whystock
ARTV
$11.29+0.49 (+4.54%)
After Hours$11.29+0.00 (+0.00%)· Last close May 4
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.